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Summary 
The effects of purified albumin species and albumin fragments (0.2-l% w/v) on short-term (4 h) 
steroid secretion by immature rat Leydig cells, in the presence of a maximally stimulating dose of 
luteinizing hormone (LH), were investigated. Human albumin and the peptic fragment (comprising 
residues l-387) enhanced pregnenolone production in isolated rat Leydig cells, whereas chicken albumin 
and the tryptic fragment (comprising residues 198-585) were not active. 
This stimulatory effect of human albumin and the peptic fragment correlated with the potential of 
these proteins to undergo a pH-dependent neutral-to-base transition as measured by circular dichroism. 
The tryptic fragment and chicken albumin did not have the potential to undergo such a transition. The 
pH-dependent conformational changes of albumin and fragments thereof occurred in parallel with a 
change in the binding affinity for testosterone and pregnenolone. 
The fatty acid oleic acid and the drug suramin, only when present in a molar ligand-to-albumin ratio 
equal to or higher than 2, inhibited the albumin-mediated stimulation of steroid production. 
These data show that the stimulatory effects of albumin species on LH-induced Leydig cell preg- 
nenolone production depend on their fatty acid content and correlate with the potential of these 
molecules to undergo conformational changes. It is unknown via which mechanisms albumin exerts its 
stimulatory effect, but the LH action through the cyclic AMP pathway seems not to be affected. 
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rTF, rat testicular fluid; bFF, bovine follicular fluid; bSA, 
bovine serum albumin; FCS, foetal calf serum; rS, rat serum; 
(o)LH, (ovine) luteinizing hormone; NEFA, non-esterified 
fatty acids; CAMP, adenosine cyclic-3’,5’-monophosphate. 
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Introduction 
In mammalian species, androgens are pro- 
duced by the Leydig cells in the testes. In the 
steroidogenic cascade, pregnenolone is the first 
product of the hormone-dependent cholesterol 
side-chain cleavage process, whereas androgens, 
like testosterone, are the final products. The Ley- 
dig cells are surrounded by interstitial fluid or 
lymph (Fawcett et al., 1973; Clark, 1975). This 
testicular fluid contains many ions and the pro- 
teins present in plasma and also locally produced 
factors (Sharpe, 1979, 1983, 1984; Waites and 
Gladwell, 1982). It has been shown previously 
that the rat testicular fluid (rTF) enhances steroid 
production in isolated rat Leydig cells in the 
presence of a maximum stimulatory dose of 
lutcinizing hormone (LH) or in the presence of 
added 22 R-hydroxycholesterol, which is an inter- 
mediate of the cholesterol side-chain cleavage 
process (Sharpe and Cooper. 1984; Rommerts et 
al., 1986; Melsert and Rommerts, 1987). Similar 
effects were also obtained with foetal calf serum 
(FCS) and bovine follicular fluid (bFF), but not 
with adult rat and bovine sera (Melsert and Rom- 
mcrts, 1987). Recent studies have shown that an 
active component in rTF which gives rise to these 
stimulatory effects is albumin (Melsert et al., 1988, 
1989). Albumin fractions, 0.2-l% (w/v), ob- 
tained from sera of several other mammalian 
species (bovine and human) were also effective in 
stimulating steroid production, whereas chicken 
serum albumin was not active (Melsert et al., 
1989). Other proteins, not structurally related to 
albumin (e.g. transferrin, ovalbumin, hemoglobin) 
were inactive (Melsert et al., 1989). Stimulation 
of steroid production was also observed after 
perfusion of intact testes with albumin-enriched 
solutions (Ewing et al., 1976). It is unknown how 
albumin can enhance the maximally LH-stimu- 
lated steroid production. 
Albumin is believed to be composed of three 
contiguous domains, each containing three loops 
(Kragh-Hansen, 1981; Brown and Shockley, 1982; 
Peters, 1985). When the pH is raised from 6 to 9, 
both human and bovine serum albumin undergo a 
conformational change, the so-called neutral-to- 
base or N-B transition (Foster, 1977; Wilting et 
al., 198Oa, b; Peters, 1985). It has recently been 
suggested that a conformational change in the 
albumin molecule may also be involved in the 
albumin-mediated transport of ligands through 
membranes of liver cells (Forker and Luxon, 1981, 
1983; Weisiger, 1985; Horie et al., 1988; Reed 
and Burrington, 1989). It was therefore postu- 
lated that the stimulatory effect of albumin on 
the Leydig cells is also connected with changes in 
the protein conformation. 
In this respect we have studied the effect of 
different types and fragments of albumin on 
steroid production by Leydig cells. The correla- 
tion between the ability to stimulate Leydig cell 
steroidogenesis and the potential to undergo con- 
formational changes of those proteins was investi- 
gated. In addition, the effects of the bound Ii- 
gands oleic acid and suramin on the stimulatory 
effect of albumin were examined. 
Material and methods 
Reagents 
Pregnenolone and testosterone, obtained from 
Steraloids, Wilton, NH, U.S.A. and [7-‘Hlpreg- 
nenolone (22.6 Ci/mmol) and [ 1,2,6,7- “Hltestos- 
terone (91.7 Ci/mmol), obtained from Amers- 
ham Nederland, Utrecht, The Netherlands, were 
used without further purification. Bovine serum 
albumin (Boseral PUR) was obtained from 
Organon Teknika, Boxtel, The Netherlands. 
Chicken serum albumin and fatty acid-free bovine 
serum albumin, both fraction V, were supplied by 
Sigma Chemical Company, St. Louis, MO, U.S.A. 
Sodium oleate was purchased from Merck, 
Darmstadt, F.R.G. and suramin was obtained 
from Bayer, Leverkusen, F.R.G. All other chemi- 
cals were of analytical grade. 
Preparation of the human albumin and the human 
albumin fragment solutions 
Human serum albumin was isolated from hu- 
man plasma according to the method described 
by Kremer (1982). The human albumin used for 
all experiments was from one batch. The peptic 
fragment (the P46 fragment) and the tryptic frag- 
ment (the T45 fragment) were obtained as de- 
scribed previously (Bos et al., 1988a, b, c, 1989a). 
The P46 fragment represents residues l-387 and 
therefore comprises domains 1 and 2 of the albu- 
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min structure. The T45 fragment corresponds to 
residues 198-585 and contains domains 2 and 3 
of the albumin structure. All protein solutions 
were deionized before use as described recently 
(Bos et al., 1988~). 
Leydig cell bioassay 
For the isolation of Leydig cells, immature 
Wistar rats, substrain R Amsterdam, were used. 
The Leydig cells were isolated from 22- to 24- 
day-old rat testes as described previously (Rom- 
merts et al., 1985). The cells were plated in 
96-well plates at a concentration of 0.5 X 10’ 
Leydig cells/well in 0.2 ml minimal essential 
medium (MEM), with Earle’s salts, non-essential 
amino acids, streptomycin (100 pg/ml), penicillin 
(100 IU/ml), Fungizone (0.6 pg/l) and 0.1% 
(w/v> bovine serum albumin, fraction V. After 1 
h, non-attached cells were removed by washing 
with the same medium. Attached cells were incu- 
bated for 3 or 4 h at 32 “C and 5% CO,/air in 
MEM that contained the sample to be tested in 
the absence or presence of LH (ovine LH, 100 
ng/ml) and inhibitors of pregnenolone metabo- 
lism (Van der Vusse et al., 1974; Melsert et al., 
1988). After incubation, the media were collected 
and stored at -20 o C. After the steroids had 
been extracted with ethylacetate (recovery greater 
than 99%‘0>, the amount of pregnenolone in cul- 
ture media was measured by radioimmunoassay 
(Van der Vusse et al., 1975; Themmen et al., 
1986). The bioassay is based on the ability of rat 
testicular fluid or albumin to cause a dose-depen- 
dent increase in pregnenolone production by iso- 
lated Leydig cells already maximally stimulated 
by LH (Melsert and Rommerts, 1987; Melsert et 
al., 1988). 
For the determination of CAMP the cells were 
lysed with 5% perchloric acid at 4” C directly 
after removal of the medium. The lysate (200 ~1) 
obtained was mixed with Tris buffer (1.1 M, 20 
~0, adjusted to pH 7 with KOH, stored at - 20 a C 
and assayed for CAMP using a commercial CAMP 
kit (Amersham Int.). 
Measurements of non-esterified fatty acids (NEFA) 
For the enzymatic determination of non- 
esterified fatty acids in various biological fluids 
and isolated albumins, the NEFA C-test was used 
(Wake Pure Chemical Industries, Osaka, Japan). 
Preparation of albumin-oleate and albumin-sura- 
min complexes 
Oleate-albumin complexes were obtained by 
adding warm solutions of sodium oleate (55 o C> 
dropwise to solutions of fatty acid-free bovine 
serum albumin (Lamers and Hulsmann, 1977). 
Oleate-albumin complexes of molar ratios 0.25, 
0.5, 1, 2, and 3 with the albumin concentration 
being 1.5 x lop4 M were prepared. In a similar 
way, suramin-albumin solutions were prepared by 
adding freshly prepared solutions of suramin to 
solutions of albumin. 
Equilibrium dialysis 
Equilibrium dialysis experiments were carried 
out with testosterone and pregnenolone as de- 
scribed previously (Bos et al., 1988b, c). The 
concentrations of human albumin, the T45 frag- 
ment, the P46 fragment and chicken albumin 
were all 6 x lo-” M and the molar steroid-to- 
protein ratios were 0.02. The protein solutions 
were made in 0.1 M phosphate or borate buffers 
with pH values between 6 and 9. In the solutions 
bound and free steroids were measured by liquid 
scintillation counting. For calculation of the asso- 
ciation constants it was assumed that all binding 
sites on each protein were equivalent and inde- 
pendent (Westphal, 1971; Wilting et al., 1980a). 
Circular dichroism (CD) 
Circular dichroic studies of the interaction be- 
tween testosterone and albumin were performed 
as described previously (Bos et al., 1988b, c>. The 
albumin concentration was 10m4 M and a molar 
testosterone-to-protein ratio of 1.0 was chosen, 
because this was found to give suitable signal-to- 
noise ratios. The observed ellipticities (e,,,) are 
the differences between the CD spectra of the 
testosterone-albumin complexes and those of the 
protein alone at a given wavelength. Molar ellip- 
ticities ([@I> were calculated as described previ- 
ously (Bos et al., 1988b, c). 
Results 
Effects of various albumin species on CAMP and 
steroid production 
Addition of fatty acid-free bovine albumin re- 
sults in a 3-fold increase in pregnenolone produc- 
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TABLE 1 
EFFECT OF BOVINE SERUM ALBUMIN ON BASAL 
AND LH-STIMULATED PREGNENOLONE AND 
CYCLIC AMP PRODUCTION BY RAT LEYDIG CELLS 
Leydig cells were incubated in the presence of various addi- 
tions: 1% (w/v) fatty acid-free bovine serum albumin (bSA) 
and/or 100 ng/ml ovine luteinizing hormone (oLH). After 3 
h the medium was collected for pregnenolone measurement 
and the cells were lysed for CAMP determination. Values are 
means of- SD (n = 3). 
Additions Pregnenolone CAMP 
(pmol/O.S X IO5 cells) (pmol/0.5 X lo5 cells) 
None 0.5*0.1 7.2 k 0.8 
hSA 1.7kO.2 6.7i 1.5 
oLH 12.1 kO.2 25.4?2.1 
oLH+hSA 32.6k0.5 27.1 k 3.2 
tion in the absence and in the presence of ovine 
LH (Table 1). For two reasons it is very unlikely 
that these effects are due to bovine LH which 
may be present in the bovine albumin prepara- 
tion used. First, in the absence of oLH there is no 
effect of albumin on the intracellular CAMP level, 
and second, albumin further increases Leydig cell 
pregnenolone production already maximally stim- 
ulated with 100 ng/ml oLH, without an effect on 
the LH-induced CAMP production (Table 1). To 
exclude interference from the LH in the various 
albumin preparations, all other experiments were 
done in the presence of this lOO-fold excess of 
oLH. 
Addition of human albumin enhances, in a 
dose-dependent manner, the pregnenolone pro- 
duction by Leydig cells in the presence of a 
maximum stimulatory dose of LH (Fig. 1). Similar 
effects have been obtained with bovine and rat 
serum albumin, whereas chicken serum albumin 
was inactive (Melsert et al., 1988, 1989). Steroid 
production in the presence of LH was also en- 
hanced by the P46 fragment, whereas the T45 
fragment did not stimulate steroid production. 
The pregnenolone production by Leydig cells was 
not influenced by various doses of chicken albu- 
min (Fig. 1). 
Determination of non-esterified fatty acids 
The amount of fatty acids in several biological 
fluids and albumin preparations was determined 
in order to establish whether or not fatty acids 
can explain why albumin in adult rat plasma and 
bovine plasma and purified chicken albumin does 
not enhance Leydig cell steroidogenesis (Melsert 
et al., 1988, 1989). Table 2 gives the molar ratio 
of fatty acid and albumin for the various biologi- 
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Fig. 1. Effect of human albumin, the P46 fragment, the T45 fragment and chicken albumin on the LH-stimulated pregnenolone 
production in isolated rat Leydig cells after a 4 h incubation. Data are expressed as percentage of control (mean k SD, n = 4). The 
control is the pregnenolone production in the presence of a maximally stimulatory dose of LH (100 ng/ml) in minimal essential 
medium (MEM) without further additions (14.4 pmol/O.S X 105 Leydig cells/4 h). B is the pregnenolone production in the absence 
of LH (0.6 pmol/OS X 10” Leydig cells/4 h). * Significantly different from control (P < 0.01, Student’s t-test). 
TABLE 2 
MOLAR RATIO OF FATTY ACID BOUND TO 
MIN FOR VARIOUS FLUIDS AND ISOLATED 
MINS 
ALBU- 
ALBU- 
Molar ratio of non-esterified fatty acids bound to albumin for 
rat serum (rS), rat testicular fluid (rTF), bovine follicular fluid 
(bFF), foetal calf serum (FCS), chicken albumin, bovine albu- 
min, human albumin, and the human albumin fragments 
(mean f SD for 3-4 determinations). 
Source Molar ratio fatty acid 
bound to albumin 
rS 2.41 k 0.05 ” 
rTF 1.13*0.04 a 
bFF 0.90 * 0.05 ‘I 
FCS 0.23 ? 0.03 ‘I 
Chicken albumin 0.58 * 0.05 
Bovine albumin 0.64 f 0.07 
Human albumin 0.70 * 0.20 
P4h fragment < 0.7 h 
T45 fragment < 0.7 h 
a Value corrected for the albumin content of the fluid, on the 
assumption that all fatty acids are bound to albumin (Sharpe, 
1979; Christensen, 1985; Melsert et al., 1988, 1989). 
’ Not determined, because we did not expect the amount of 
fatty acid bound to the proteins to change during the 
purification of the fragments (Bos et al., 1988a, b, cl. 
cal fluids, bovine albumin, chicken albumin, hu- 
man albumin, and the human albumin fragments. 
It is obvious that for all isolated proteins, the 
molar ratio of fatty acid bound to protein is less 
than 1. For rat testicular fluid, bovine follicular 
fluid, and foetal calf serum, this ratio is approxi- 
mately equal to 1 or less than 1. However, in rat 
serum the fatty acid to albumin ratio is 2.4. 
Effects of the ligands oleic acid and suramin in the 
presence and in the absence of albumin 
Fatty acid-free bovine serum albumin stimu- 
lates LH-induced steroid production in a dose- 
dependent manner, giving rise to a 25fold in- 
crease at an albumin concentration of 1% w/v 
(Fig. 2). Albumin-oleate complexes, with a molar 
ratio of oleic acid bound to albumin equal to or 
less than 1, are still active in stimulation of steroid 
production. The complex is not active anymore, 
when the molar ratio of fatty acid-to-albumin is 2 
(Fig. 2). 
Since it is possible that the effect of the vari- 
ous albumin-oleate complexes on the steroid pro- 
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duction in Leydig cells is caused by increasing 
amounts of unbound fatty acids, the effects of 5.3 
nM, 0.12 PM, 1.72 PM, and 6.36 PM oleate on 
the steroid production, in the absence of albumin 
were studied. These oleate concentrations corre- 
spond to the concentrations of unbound fatty 
acids that are present at oleate-albumin com- 
plexes of increasing molar ratios of 1, 3, 5, and 7, 
respectively (the albumin concentration being 1.5 
X lop4 MI (Spector and Fletscher, 1978). We 
found that only at the highest concentration of 
6.36 PM oleate, steroid production was inhibited 
to approximately 60% of the control values (re- 
sults not shown). 
Since fatty acids can be metabolized by Leydig 
cells, the previous data may underestimate the 
inhibitory effect of fatty acids. We have therefore 
also investigated the effect of suramin bound to 
albumin. Suramin was chosen as a ligand, be- 
cause it cannot be metabolized and is unable to 
pass through membranes of liver and kidney cells 
(Vansterkenburg et al., 1989). The level of 
suramin during the incubation period can there- 
fore be expected to be constant. Preliminary ex- 
periments indicated that suramin does not affect 
the N-B transition. Only at a molar ratio of 
m 
t 
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Fig. 2. Effect of oleate-albumin complexes on the LH-stimu- 
lated pregnenolone production in isolated rat Leydig cells 
after a 4 h incubation in the presence of 1% (w/v) fatty 
acid-free bovine serum albumin. Oleate was present in molar 
oleate-to-albumin ratios of 0.25 (A), 0.5 (B), 1.0 (Cl and 2.0 
CD). Data are expressed as percentage of control (mean + SD, 
n = 6). For further conditions see the legend to Fig. 1. 
I D 
with 
suramin 
Fig. 3. Effect of suramin-albumin complexes on the LH- 
stimulated pregnenolone production by isolated rat Leydig 
cells after a 4 h incubation in the presence of 1% (w/v) 
human serum albumin. Suramin was present in molar 
suramin-to-albumin ratios of 0.2 (A), 0.5 (B), I.0 (0, and 2.0 
(D). Data are expressed as percentage of control (mean k SD, 
n = 3). For further conditions see the legend to Fig. 1. 
suramin-to-albumin of 2, the stimulatoty effect of 
albumin on the steroid production has been de- 
creased significantly (Fig. 3). Suramin, in concen- 
trations up to 8.5 PM (values corresponding to 
the concentrations of unbound suramin in the 
presence of suramin-albumin complexes with a 
ratio up to 2, respectively) did not affect Leydig 
cell steroidogenesis (results not shown). 
Conformational aspects 
The various albumin preparations were also 
characterized with respect to pH-dependent con- 
formational changes as reflected by changes in 
steroid binding and circular dichroism. 
Equilibrium dialysis experiments with steroids 
were performed in order to investigate the pH 
dependency of the steroid binding by intact hu- 
man and chicken albumin and by the P46 and 
T45 fragment of human albumin. The pH depen- 
dency of the testosterone binding to these pro- 
teins is shown in Fig. 4. The apparent association 
constants (nK), calculated from the data from the 
dialysis experiments with testosterone, are given 
in Table 3. The data show that the binding of 
steroids to human albumin and the P46 fragment 
is clearly pH dependent, whereas the affinity of 
steroids for chicken albumin and the T45 frag- 
ment is pH independent. Similar data, although 
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Fig. 4. Effect of the pH on the binding of testosterone to 
human albumin, the human albumin fragments and chicken 
albumin. The percentage of unbound testosterone is plotted 
as a function of the pH. (A) Human albumin (m) and chicken 
albumin (0). (B) Human albumin (m), the P46 fragment ( ,) 
and the T45 fragment (0). Protein concentrations were hX 
10-s M and testosterone was added in a steroid-to-protein 
ratio of 0.02. 
less pronounced, were obtained when preg- 
nenolone was used instead of testosterone. 
Circular dichroic experiments were performed 
with human and chicken albumin in order to test 
whether the pH-dependent changes in steroid 
binding occur in parallel with conformational 
changes. The testosterone binding to human al- 
bumin induces an extrinsic Cotton effect that has 
its maximum at 303 nm (data not shown). Thus, 
the difference in the CD spectra for testosterone- 
TABLE 3 
APPARENT ASSOCIATION CONSTANTS 
The apparent association constants (nK) for the binding of 
testosterone to various proteins (mean f SD for 4-6 determi- 
nations). 
Protein nKx lo-” Mm’ 
PH6 pH9 
Human albumin 1.9? 0.6 14.3 * 3.7 
Chicken albumin 1.x*0.1 1.9&0.2 
P46 fragment 2.1 io.1 4.4* 1.1 
T4.5 fragment 1.8 * 0.4 2.2 * 0.3 
- 
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Fig. 5. Circular dichroism experiments with human and 
chicken albumin. The figure shows the molar ellipticity [0] of 
the human albumin-testosterone complex (H) and of the 
chicken albumin-testosterone complex (0) as a function of the 
pH. The protein concentrations were IO-” M and testos- 
terone was present in a testosterone-to-protein ratio of 1. 
Measurements were performed at 303 nm for human albumin 
and 312 nm for chicken albumin in phosphate or borate 
buffers, I = 0.1. 
albumin complex and for the albumin alone is 
most pronounced at 303 nm. The effect of the pH 
on the molar ellipticity [@I is shown in Fig. 5. It 
can be seen that the molar ellipticity increases 
with increasing pH, with a maximal effect around 
pH 8. Testosterone also induces extrinsic Cotton 
effects, with a maximum at 312 nm when chicken 
albumin is used. However, for chicken albumin 
the molar ellipticity is pH independent (Fig. 5). 
In previous work it has been shown that the 
conformational state of the P46 fragment is clearly 
pH dependent, whereas the T45 fragment does 
not show a pH-dependent conformational change 
(Bos et al., 1988b, c, 1989a). 
Discussion 
Purified albumin preparations from several 
species, the P46 fragment of human albumin, and 
also albumin present in rTF, bFF and FCS en- 
hance pregnenolone production in Leydig cells in 
the presence of a maximally stimulating dose of 
LH. In contrast, chicken albumin, the T45 frag- 
ment of human albumin, and the albumin present 
in rat and bovine sera are not active when added 
in similar concentrations of 0.2-l% w/v (Melsert 
et al., 1988, 1989, and results presented in this 
study). These data raise at least two important 
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questions. Firstly, why do certain species of albu- 
min further enhance LH-stimulated steroidogen- 
esis, whereas others are inactive? And secondly, 
how can the activity of these albumin species be 
inhibited by bound ligands, such as fatty acids? 
We have tried to answer these two questions in 
relation with conformational properties of the 
various albumin species. 
It is known that the albumin conformation can 
be modified by changes in pH (the so-called 
neutral-to-base or N-B transition) or by the addi- 
tion of ligands such as calcium ions (Peters, 1985). 
Previous work has shown that between pH 6 and 
9, bovine albumin, human albumin and the P46 
fragment show an N-B related transition (Wilt- 
ing et al., 1980a, b; Peters, 1985; Bos et al., 1988b, 
c, 1989a). In contrast, the T45 fragment and 
chicken albumin do not show an N-B related 
transition (Bos et al., 1988c, 1989a, and this pa- 
per). These data show that there is a correlation 
between the stimulatory effect of the type of 
albumin or fragment and the potential of these 
proteins to undergo a conformational change. 
In a recent paper, we investigated the molecu- 
lar mechanism of the N-B transition in human 
albumin (Bos et al., 1989a). Since at least five 
histidine residues in the first domain of the albu- 
min structure are involved in the N-B transition, 
we proposed that the N-B transition is induced 
by the severance of salt bridges between these 
positively charged histidine residues in domain 1 
and anionic residues in domain 2 and 3. It may be 
possible that these transitions play a role in the 
structural changes in albumin molecules upon 
adsorption to solid surfaces (Norde and Lyklema, 
1978; Akaike and Sukarai, 1979; Soderquist and 
Walton, 1980; Castillo et al., 1984; Norde et al., 
1986; Hlady and Andrade, 1988; Reed and Bur- 
rington, 1989), or during interaction between al- 
bumin and cellular membranes (Weisiger, 1985; 
Ghinea et al., 1988; Schnitzer et al., 1988). Re- 
cently, Reed and Burrington (1989) presented 
evidence for conformational changes of the albu- 
min molecule upon binding to intact hepatocytes. 
It is therefore not unlikely that upon interaction 
with the Leydig cell membrane, albumin under- 
goes a conformational change that is somehow 
transduced through the cell membrane and fi- 
nally leads to a stimulation of Leydig cell 
steroidogenesis. We have observed that albumin 
can increase steroid production in the absence 
and in the presence of LH. Albumin may interact 
with LH and this could result in a decreased 
binding of LH to its receptor in the presence of 
bovine serum albumin (Hunter et al., 1982). How- 
ever, albumin further increases steroid produc- 
tion in the presence of a maximally stimulating 
dose of LH, without an effect on the go- 
nadotrophin-induced CAMP production (this 
study). In a previous article we demonstrated that 
albumin can also enhance steroid production in 
the presence of 22 ~-hydro~cholesterol (Melsert 
et al., 19881. These findings indicate that albumin 
enhances steroid production via a peculiar, yet 
unknown mechanism not involving LH-activated 
pathways. 
A hypothetical model for the albumin effect 
on steroid production in Leydig cells can be de- 
scribed as follows. Albumin interacts with the 
Leydig cell membrane and this initiates the for- 
mation of transient salt bridges between his- 
tidines and/or other positively charged residues 
located on the top of the albumin molecule and 
negatively charged groups in the membrane ma- 
trix. As a result, the internal coherence of the 
albumin molecule is weakened by the disappear- 
ance of salt bridges between the histidines in 
domain 1 and anionic residues in domain 2 and 3. 
This leads to an N-E like conformational change 
in the albumin molecule. Due to the collision 
interactions between albumin and the cell mem- 
brane the membrane matrix may become per- 
turbed. This could result in an increased avail- 
ability of cholesterol from the membrane or in an 
increase in membrane phosphoinositide turnover 
(Langlais and Roberts, 1985). Detailed experi- 
ments are necessary to reveal which effect of 
albumin action is most likely to explain the stimu- 
lation of steroid production. The hypothetical 
collision interaction between albumin and the cell 
membrane can also account for the relatively high 
doses of albumin (appr. 10m4 MI which are re- 
quired before an effect on steroid production can 
be demonstrated. This model also does not re- 
quire specific receptors with high affinity for al- 
bumin which have not been identified yet (Chris- 
tensen et al., 1985; Reed and Burrington, 1989). 
Several membrane glycoproteins that show 
affinity for albumin have been isolated from cap- 
illary endothelial cells (Ghinea et al., 1988; 
Schnitzer et al., 1988). These membrane glyco- 
proteins are of interest for their possible role in 
the translocation of albumin for intravascular to 
extravascular space. Perhaps, in a similar fashion, 
one or more glycoproteins in the Leydig cell 
membrane could interact with albumin. In this 
respect, Christensen et al. (1985) using electron 
microscope immunocytochemist~, showed a thin 
layer of albumin remaining on the surface of 
Leydig cell in situ after the surrounding albumin 
was flushed away by perfusion. This retention of 
albumin was strongest on the microvilli and was 
absent on the surface of many other cell types 
that are normally in contact with albumin. 
The inhibition of aIbumin-mediated stimula- 
tion of the steroid production by negatively 
charged ligands poses another question. Fatty 
acids and suramin, complexed to albumin at ra- 
tios higher than 2, inhibit the albumin-mediated 
stimulation of steroid production. This may be 
possible by blocking the interaction between al- 
bumin and the Leydig cell membrane. King (1987) 
suggested that binding of fatty acids to albumin 
molecutes is not favourable for the interaction of 
albumin with the red cell membrane. Similar ef- 
fects of fatty acids have been reported in the 
binding properties of lipoproteins to low density 
lipoprotein (LDL) receptors (Bihain et al., 1989) 
and in the binding of steroid hormones to specific 
binding globulins and hormone receptors (Benas- 
sayag et al., 1979. 1986; Martin et al., 1986, 1988: 
Bregengord et al., 1987; Nunez, 1987; Mooradian 
et al., 1988). Fatty acids and suramin in the 
concentrations used do not inhibit the N-B tran- 
sition of albumin (Peters, 1985). 
In various purified albumins the molar NEFA- 
to-protein ratios were found to be less than 1. In 
rat serum, however, levels of fatty acids are much 
higher. This difference in fatty acid content be- 
tween purified aIbumins and complete sera can 
explain why purified human, bovine and rat albu- 
min can enhance steroid production by Leydig 
cells in the presence of LH, whereas albumin in 
rat and bovine serum is not active (MeIsert et al., 
1987, 1988, 1989). The finding that relatively high 
doses of sera can even exert an inhibition of 
steroid production in Leydig cells stimulated with 
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LH (Melsert et al., 1987) is in accordance with 
the finding of Meikle et al. (1989) that non- 
esterified fatty acids (NEFA, such as oleic acid 
and linoleic acid) can be potent inhibitors of 
LH-stimulated testosterone production. This in- 
hibition is not caused by an effect of NEFA on 
the binding of LH to the cell receptor (Meikle et 
al., 1989). From other studies it is known that 
fatty acids can alter the structure and functioning 
of plasma cell membranes (Klausner et al., 1980a, 
b; MacDonald and MacDonald, 1988) and cells 
can even be intoxicated (Mather et al., 1979; 
Wolfe et al., 1980). 
In our initial studies with rat testicular fluid 
(rTF) we started with the hypothesis that rTF 
contained one ore more biologically active factors 
not present in rat serum (Sharpe and Cooper, 
1984; Rommerts et al., 1986; Melsert et al., 1987). 
In the following studies we demonstrated with 
our short-term (4 h) bioassay system that serum 
albumin purified from normal rat rTF accounted 
for the majority of the steroid stimulating activity 
in rTF (Melsert et al., 1988, 1989). Since serum 
and rTF contain similar concentrations of albu- 
min, we suggested that the lack of activity in 
serum was due to an unidentified serum inhibitor 
of Leydig cell function (Melsert et al., 1987, 1988). 
From the present data it can be derived that fatty 
acids in serum can act as such inhibitors of Ley- 
dig cell steroidogenesis. The short-term stimulat- 
ing effect of rTF on steroid production appears 
to be mainly due to the action of albumin in rTF, 
which is ‘activated’ by the removal of bound fatty 
acids. These fatty acids may be used as energy 
substrates for testicular cells (Fritz, 1961). 
It cannot be concluded from our studies that 
biologically active factors, other than albumin (e.g. 
growth factors), are absent in rTF. For detection 
of such factors other bioassay systems measuring 
steroid secretion or [ 3H]thymidine incorporation 
by isolated cells in long-term cultures (> 4 h) are 
more suitable (Verhoeven and Cailleau, 1985, 
1987, 1990; Risbridger et al., 1987; Hedger et al., 
1990). 
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